We are live on ! Find out more
ACM

Ashford Capital Management Portfolio holdings

AUM $809M
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+9.69%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.15%
5 Year Est. Return
+109.93%
10 Year Est. Return
+1,281.06%
AUM
$447M
AUM Growth
+$26.2M
Cap. Flow
-$12.4M
Cap. Flow %
-2.77%
Top 10 Hldgs %
39.1%
Holding
107
New
8
Increased
32
Reduced
41
Closed
3

Top Buys

Rank Stock Value
1
MANH icon
Manhattan Associates
MANH
+$3.4M
2
MDSO
Medidata Solutions, Inc.
MDSO
+$2.49M
3
STMP
Stamps.com, Inc.
STMP
+$2.4M
4
VSAT icon
Viasat
VSAT
+$2.25M
5
SUPN icon
Supernus Pharmaceuticals
SUPN
+$1.43M

Top Sells

Rank Stock Value
1
EBIX
Ebix Inc
EBIX
+$9.54M
2
AMRI
Albany Molecular Research Inc
AMRI
+$6.23M
3
NVEE
NV5 Global
NVEE
+$2.27M
4
MKTX icon
MarketAxess Holdings
MKTX
+$1.96M
5
FLTX
Fleetmatics Group PLC
FLTX
+$1.59M

Sector Composition

Rank Sector Weight
1 Technology 27.98%
2 Industrials 16.94%
3 Financials 11.98%
4 Healthcare 11.53%
5 Real Estate 2.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADBE icon
76
Adobe
ADBE
$99.5B
$536K 0.12%
5,600
– –
MDLZ icon
77
Mondelez International
MDLZ
$79.5B
$523K 0.12%
11,490
– –
IQI icon
78
Invesco Quality Municipal Securities
IQI
$522M
$490K 0.11%
35,447
-4,964
-12% -$67K
BMY icon
79
Bristol-Myers Squibb
BMY
$133B
$485K 0.11%
6,596
– –
WEC icon
80
WEC Energy
WEC
$35.7B
$478K 0.11%
7,313
– –
EXPD icon
81
Expeditors International
EXPD
$22B
$476K 0.11%
9,700
– –
META icon
82
Meta Platforms (Facebook)
META
$1.42T
$457K 0.1%
+4,000
New +$461K
TEVA icon
83
Teva Pharmaceuticals
TEVA
$40.8B
$452K 0.1%
9,000
-1,200
-12% -$63.9K
DHR icon
84
Danaher
DHR
$137B
$439K 0.1%
6,474
-684
-10% -$44.7K
DD
85
DELISTED
Du Pont De Nemours E I
DD
$436K 0.1%
6,729
-522
-7% -$34.3K
CVS icon
86
CVS Health
CVS
$133B
$426K 0.1%
4,450
– –
KMI icon
87
Kinder Morgan
KMI
$71.7B
$402K 0.09%
+21,500
New +$383K
VZ icon
88
Verizon
VZ
$195B
$389K 0.09%
6,970
– –
JNJ icon
89
Johnson & Johnson
JNJ
$618B
$382K 0.09%
3,150
+200
+7% +$22.7K
T icon
90
AT&T
T
$159B
$379K 0.08%
11,611
– –
MMM icon
91
3M
MMM
$90.9B
$364K 0.08%
2,484
– –
CVX icon
92
Chevron
CVX
$392B
$343K 0.08%
3,270
– –
CMD
93
DELISTED
Cantel Medical Corporation
CMD
$320K 0.07%
4,660
-1,599
-26% -$110K
MELI icon
94
Mercado Libre
MELI
$95.2B
$317K 0.07%
+2,250
New +$292K
MRK icon
95
Merck
MRK
$322B
$300K 0.07%
+5,450
New +$290K
APC
96
DELISTED
Anadarko Petroleum
APC
$272K 0.06%
5,112
– –
WU icon
97
Western Union
WU
$1.98B
$269K 0.06%
14,035
– –
LGTY
98
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$262K 0.06%
25,000
– –
ILMN icon
99
Illumina
ILMN
$31B
$253K 0.06%
+1,850
New +$263K
CG icon
100
Carlyle Group
CG
$16.6B
$245K 0.05%
15,100
-31,500
-68% -$516K
1 2 3
4
5

Similar funds

SSG
Summit Securities Group New York $810M AUM 27.35% 1-Year Est. Return
BBI
Baxter Bros Inc Riverside, Connecticut $810M AUM 16.24% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
DWA
Dorsey Wright & Associates Pasadena, California $807M AUM 65.46% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
OC
Oarsman Capital Milwaukee, Wisconsin $806M AUM 19.96% 1-Year Est. Return
RIM
Redwood Investment Management Scottsdale, Arizona $805M AUM 15.01% 1-Year Est. Return

Ashford Capital Management's Q2 2016 Portfolio in Review

As of Q2 2016, Ashford Capital Management held 107 positions worth $447M, up 6.2% from $421M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Ashford Capital Management's Q2 2016 filing shows 8 new, 32 increased, 41 reduced and 3 closed positions. Its largest new stake was Manhattan Associates: 54,600 shares worth $3.5M. The largest sale was Ebix Inc, an estimated $9.54M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Industrials and Financials.

  • Ashford Capital Management's largest Q2 2016 buy was Manhattan Associates: 54,600 shares worth $3.5M.
  • Ashford Capital Management added most to Medidata Solutions, Inc. in Q2 2016, an estimated $2.49M increase.
  • Ashford Capital Management's biggest Q2 2016 reduction was Ebix Inc, cutting an estimated $9.54M.
  • Ashford Capital Management fully exited Albany Molecular Research Inc in Q2 2016, selling an estimated $6.23M.
  • Ashford Capital Management's ten largest holdings make up 39% of its $447M portfolio in Q2 2016.
  • Ashford Capital Management opened 8 new positions and closed 3 in Q2 2016.
  • Ashford Capital Management's portfolio value rose 6.2% quarter-over-quarter to $447M.

Based on Ashford Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.